KYLYS AESTHETICS SA

KYLYS and newly KYLYS Aesthetics focus on developing a unique dermal filler product based on hyaluronic acid with significant competitive advantages due to the innovative technology. KYLYS' technology is already protected by a patent. The dermal filler products prototypes are developed under an Innosuisse project. The technology has shown relevant first prototypes with solid PoP/PoC, which brings the company to the status to raise the investment needed to go into the next development stages. This development stage corresponds to Technology Readiness Level 4, in the early development phase of the product. KYLYS Aesthetics plans to raise CHF 900K from non-dilutive funding and seed financing during the next 12 months. The technology can also be used for medical and surgical needs.